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Stress Doppler Echocardiography in Relatives of Patients
With Idiopathic and Familial Pulmonary
Arterial Hypertension
Results of a Multicenter European Analysis of Pulmonary Artery Pressure
Response to Exercise and Hypoxia
Ekkehard Grünig, MD; Sylvia Weissmann, PhD; Nicola Ehlken, BSc; Anna Fijalkowska, MD;
Christine Fischer, PhD; Thierry Fourme, MD; Nazzareno Galié, MD; Ardeschir Ghofrani, MD;
Rachel E. Harrison, MRCPCH; Sandrine Huez, MD; Marc Humbert, MD; Bart Janssen, PhD;
Jaroslaw Kober, MD; Rolf Koehler, PhD; Rajiv D. Machado, PhD; Derliz Mereles, MD;
Robert Naeije, MD; Horst Olschewski, MD; Steeve Provencher, MD; Frank Reichenberger, MD;
Kathleen Retailleau, MD; Guido Rocchi, MD; Gérald Simonneau, MD; Adam Torbicki, MD;
Richard Trembath, FRCP; Werner Seeger, MD
Background—This large, prospective, multicentric study was performed to analyze the distribution of tricuspid
regurgitation velocity (TRV) values during exercise and hypoxia in relatives of patients with idiopathic and familial
pulmonary arterial hypertension (PAH) and in healthy control subjects. We tested the hypothesis that relatives of
idiopathic/familial PAH patients display an enhanced frequency of hypertensive TRV response to stress and that this
response is associated with mutations in the bone morphogenetic protein receptor II (BMPR2) gene.
Methods and Results—TRV was estimated by Doppler echocardiography during supine bicycle exercise in normoxia and
during 120 minutes of normobaric hypoxia (FIO212%; 4500 m) in 291 relatives of 109 PAH patients and in 191
age-matched control subjects. Mean maximal TRVs were significantly higher in PAH relatives during both exercise and
hypoxia. During exercise, 10% of control subjects but 31.6% of relatives (P0.0001) exceeded the 90% quantile of
mean maximal TRV seen in control subjects. Hypoxia revealed hypertensive TRV in 26% of relatives (P0.0029).
Among control subjects, TRV at rest was not related to age, sex, body mass index, systemic blood pressure, smoking
status, or heart rate. Within kindreds identified as harboring deleterious mutations of the BMPR2 gene, a hypertensive
TRV response occurred significantly more often compared with those without detected mutations.
Conclusions—Pulmonary hypertensive response to exercise and hypoxia in idiopathic/familial PAH relatives appears as a
genetic trait with familial clustering, being correlated to but not caused by a BMPR2 mutation. The suitability of this trait to
predict manifest PAH development should be addressed in long-term follow-up studies. (Circulation. 2009;119:1747-1757.)
Key Words: echocardiography  echocardiography, stress  genetics  hypertension, pulmonary  hypoxia
 pulmonary heart disease
Idiopathic (I) or familial (F) pulmonary arterial hyperten-sion (PAH) is chronically progressive and believed to
evolve slowly, with an asymptomatic increase in pulmonary
arterial constriction and remodeling over several years.1,2 In
most patients, the disease is not diagnosed until pulmonary
artery pressure is markedly elevated and right ventricular
dysfunction has begun.3 The results of the Endothelin Antag-
onist tRial in miLdlY symptomatic PAH (EARLY) indicate
that diagnosis and treatment of PAH even a few months
earlier might improve time to clinical worsening and empha-
size that PAH needs to be diagnosed and treated in the early
stages.4 Because mutations of the bone morphogenetic pro-
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tein receptor II (BMPR2) have been identified in patients with
I/FPAH,5–7 noninvasive methods aiming at the identification
of persons at risk for the disease have gained attention. In a
previous study, family members of FPAH patients who shared
the risk haplotype with the index patient showed an increased
pulmonary artery systolic pressure (PASP) rise during exercise
as assessed by echocardiography.8,9 These results suggest that
asymptomatic gene carriers, in the absence of manifest pulmo-
nary hypertension, might be identified by their enhanced PASP
response to supine bicycle exercise.8
Clinical Perspective p 1757
Most pulmonary hypertension (PH) guidelines recommend
a screening by echocardiography at rest for patients at risk of
PAH, including relatives of PAH patients and patients with
systemic sclerosis.10 Although echocardiography at rest has
been established in the diagnosis of manifest PH,11 it has
rarely been evaluated in at-risk groups. Furthermore, echo-
cardiography at rest has been shown to have a low sensitivity
and specificity in subjects in whom PAH is not clinically
evident. Echocardiography during exercise may be a more
promising approach to detect early stages of PAH. However,
the feasibility of using stress Doppler echocardiography for
this indication has not been assessed. Another problem is that
no confirmed consensus exists as to which PASP threshold is
diagnostically relevant for exercise-induced PH, particularly
if stress echocardiography is applied. A high threshold would
increase specificity but decrease sensitivity.12 Only a few
invasive and noninvasive studies have analyzed the normal
values for pulmonary artery pressures during exercise and
prolonged hypoxia. Gurtner et al13 and Janosi et al14 showed that
in healthy subjects the systolic pressures do not exceed
40 mm Hg even during heavy exercise. Bossone et al15 found
higher values in athletes as a consequence of increased flow and
left atrial pressure. Nevertheless, even in athletes, PASP did not
exceed 40 mm Hg until high workloads (160 W) had been
reached.15
Beside stress Doppler echocardiography, assessment of
tricuspid regurgitation velocity (TRV) during hypoxia may be
another interesting noninvasive screening tool for early PAH
manifestation. In previous studies, subjects susceptible to
high-altitude pulmonary edema displayed a hypertensive PASP
increase not only during hypoxia16,17 but also during exercise in
normoxia.18,19 Thus, a hypertensive increase in pulmonary artery
pressure during exercise and hypoxia may be linked.
In the present multicentric study, we tested the hypothesis
that relatives of I/FPAH patients display an enhanced fre-
quency of a hypertensive rise in pulmonary artery pressure in
response to exercise and hypoxia compared with unrelated
healthy control subjects. To perform this test, threshold
values of “normal” and “hypertensive” TRV values under
conditions of exercise and hypoxia were assessed in the
healthy control group by predefined criteria. Moreover, in the
relatives of I/FPAH patients with known BMPR2 mutation,
we asked whether such hypertensive pulmonary artery pres-
sure response to exercise and hypoxia might be linked to the
presence of this mutation.
This is the first large-scale multicenter study of Doppler
stress echocardiography in pulmonary hypertension. A long-
standing European tradition exists of multicenter effective-
ness in stress echocardiography studies in coronary artery
disease and in dilated cardiomyopathy.20,21 Our study might
extend the basis for incorporation of PH in the indications for
stress echocardiography.
Methods
Study Population and Design
We assessed relatives 12 years of age of unrelated adult index
patients with manifest idiopathic or familial PAH who did not have
any intervening cardiac or pulmonary disease (Figure 1). In all index
patients, the diagnosis was established at the PH-specialized centers
according to current guidelines.1,10,11 All patients underwent a
detailed clinical examination, including right heart catheterization.
Testing for vasoreactivity and left heart catheterization were per-
formed when clinically indicated. The control group consisted of
age- and sex-matched subjects who were recruited from the employ-
ees of the participating hospitals and from students of medical and
physiotherapy schools. Age and sex matching was performed in each
study center as a group matching. Therefore, clinical assessment of
family members and control subjects included a medical history,
physical examination, 12-lead ECG, echocardiography at rest and
during supine bicycle exercise at normoxia, and echocardiography
during 120 minutes of normobaric hypoxia (FIO212%). In relatives
or control subjects with hypertensive PASP, secondary reasons were
excluded by a cascade of clinical examinations, including echocar-
diography of the left heart, chest x-ray, pulmonary function tests, and
measurement of arterial blood gases. Acute or chronic pulmonary
and cardiac diseases were ruled out in all family members and
control subjects. Blood samples were collected for genetic analysis
Figure 1. Study population. Left, healthy control
subjects and relatives who performed supine bicy-
cle exercise; right, subjects assessed during 120
minutes of hypoxia.
1748 Circulation April 7, 2009
 by guest on September 29, 2012http://circ.ahajournals.org/Downloaded from 
from all patients and relatives. The protocol of this study was
approved by the ethics committees of the participating universities,
and the participants or their parents gave written informed consent.
Echocardiography
Two-dimensional and color-flow guided continuous-wave Doppler
echocardiographic recordings were performed by experienced car-
diac sonographers using 2.5-MHz duplex probes and conventional
equipment (HP [Palo Alto, Calif] Sonos 2000, Acuson Sequoia
C512, HP Sonos 4500, GE [Tampa, Fla] Vivid 7, Aloka SSD-5500,
and Aloka SSD-2200) (1) at rest and during stress echocardiography
in normoxia and (2) during baseline in normoxia and at 45, 90, and
120 minutes of hypoxia (FIO212%). PASP was estimated from
peak tricuspid regurgitation jet velocities according to the modified
Bernoulli equation: PASP4(V)2RAP, where V is the peak
velocity (in m/s) of tricuspid valve regurgitant jet (TRV) and RAP is
right atrial pressure. In the absence of obstruction to right ventricular
outflow, right ventricular systolic pressure equals PASP.22 For all
calculations, the mean value of at least 3 TRV measurements was
used. Right atrial pressure was estimated from characteristics of the
inferior vena cava.23 If it was 20 mm in diameter and decreased
during inspiration, we add 5 mm Hg, which was the case in all
subjects. Left ventricular and left atrial size, left ventricular ejection
fraction, and diameters of the left ventricular wall were obtained in
all subjects. Subjects with abnormal values for left ventricular size,
septal thickness (12 mm), and left ventricular ejection fraction were
excluded. Diastolic left ventricular function was evaluated with pulsed-
wave Doppler in the mitral and tricuspid inflow measuring E/A and
E/e. Subjects with suspected diastolic dysfunction had to be excluded.
Stress Doppler Echocardiography
Relatives and control subjects underwent a standardized echocardi-
ography Doppler bicycle exercise on a variable-load supine bicycle
ergometer (ER 900 EL, Ergoline, Bitz, Germany) as described
previously.8 Workload was increased by 25 W every 2 minutes to an
exercise capacity or symptom-limited maximum. TRV, heart rate,
and systemic blood pressure were analyzed at each stage. Echocar-
diographic assessment was continuously recorded on videotape and
stored in DICOM format for further offline analysis.
Measurements During Hypoxia
Measurements during hypoxia were performed in 3 of the 6
participating centers with a gas mixture of 12% oxygen and 88%
nitrogen corresponding to an altitude of 4500 m. In Heidelberg,
measurements were performed in a hypoxic chamber; in Brussels
and Giessen, a facial mask was used. The subjects were examined in
the supine position, and oxygen saturation and heart rate were
recorded continuously with a fingertip pulse oximeter (Ohmeda Biox
3700, Ohmeda, Louisville, Colo).
Genetic Analysis
BMPR2 mutation analysis was performed in all index patients and
relatives with denaturing high-performance liquid chromatography
and cycle sequencing with Big Dye terminators (version 1.1, Applied
Biosystems, Foster City, Calif) on an ABI 3700 sequencer as
described previously.7,9
Quality Control
Echocardiography measurements and genetic analyses were sub-
jected to strict quality control. Great attempts were made to obtain
high-quality TRV profiles and reliable genetic data. All participating
centers used the same supine bicycle tables and protocols for
exercise and hypoxia. At the start of this project, experienced
echocardiographic examiners at all centers were trained in the
applied techniques. Recordings were stored in DICOM format and
on videotape and were centrally reanalyzed offline in random order
and in a blinded fashion. The offline readings were used for
calculations. The sonographers who assessed TRV had no knowl-
edge of the genetic data. BMPR2 mutation screening was performed
in 2 independent Institutes of Human Genetics in London and
Heidelberg with crossover analysis for quality control. Genetic
investigators were blinded to clinical data.
Statistical Analysis
Data in figures and tables are given as meanSD. All reported
values of TRV represent the mean of at least 3 measurements.
Baseline characteristics of relatives and control subjects were com-
pared by 2-tailed Student’s t test. For comparison of categorical
variables, the 2 test was performed. The comparisons of groups for
TRV at rest and during exercise and hypoxia were performed by
ANOVA. These tests were adjusted for centers and familial relations.
Therefore, the mean values obtained in each family and center were
used as covariates. For descriptive analysis of TRV values at rest and
during exercise and hypoxia, histograms, Q-Q plots, and the method
of kernel density estimation24 were used. Correlation coefficients
adjusted for familial relationships were used to describe TRV
measurements during exercise and hypoxia. For the comparisons of
baseline with exercise and baseline with hypoxia, paired t tests were
performed. Comparisons of the proportion of family members with
exaggerated TRV response between BMPR2-positive and BMPR2-
negative subjects were performed by with Proc Genmod, SAS
version 9.1 (SAS Institute, Inc, Cary, NC), with the logistic link
function taking into account clustered measurement per family.
Comparisons of TRV values at exercise and hypoxia were adjusted for
multiple comparisons. Values of P0.025 remained significant. Unad-
justed values of P0.05 were considered statistically significant.
The authors had full access to and take full responsibility for the
integrity of the data. All authors have read and agree to the
manuscript as written.
Results
Study Population
In total, 122 index patients, 344 relatives, and 224 unrelated
control subjects were recruited. Thirteen index patients were
excluded either for lack of relatives assessed clinically or for
lack of blood samples. Thirty-three control subjects (14.7%)
and 53 relatives (15.4%) had to be excluded because of
inadequate Doppler signals during exercise or as a result of a
diagnosis of diseases likely affecting pulmonary artery pres-
sure such as systemic arterial hypertension and diastolic left
ventricular dysfunction (Figure 1). Thus, the final study
group performing stress echocardiography included 482 sub-
jects, 191 unrelated control subjects, and 291 family members
from 109 unrelated index patients recruited in 6 centers from
5 European countries (Figure 1, Table 1). In the group
assessed during hypoxia, 13 control subjects (10.3%) and 15
relatives (10.2%) had to be excluded because of inadequate
Doppler profiles and/or inadequate hypoxemia. In 1 relative
and 3 control subjects, the assessment had to be terminated
after 60 minutes of hypoxia because of nausea, headache, or
low O2 saturation (SaO2, 38%), respectively. Thus, the final
study group included 244 subjects, 113 control subjects, and
131 relatives who completed 120 minutes of hypoxia (Figure
1). Relatives and control subjects had similar demographic
data, blood pressures, heart rates, and proportion of smokers
(Table 2). Hemoglobin values, left ventricular size, left
ventricular systolic and diastolic function, and the diameter of
the left atrium (mean left atrial diameter, 29.295.27 mm in
control subjects and 29.285.5 mm in family members) were
normal in all control subjects and family members. Mitral
valve prolapse without regurgitation was seen in 21 family
members (9.9%) and in 7 control subjects (4.3%). Five family
members (2.4%) and 1 control subject (0.6%) had a very mild
Grünig et al Disposition to PAH 1749
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thickening of the aortic valve; in 3 family members (1.4%)
and 1 control subject (0.6%), a mild aortic regurgitation was
detected. Because the changes were very mild, we did not
exclude these subjects.
Distribution of TRV at Rest and During Exercise
and Hypoxia in Control Subjects and Relatives
TRV at rest showed a normal distribution in the control
subjects (Figure 2A and Figure 3B). Family members and
control subjects reached similar levels during exercise testing
(peak heart rate: family members, 14622 bpm; control
subjects, 15519 bpm; peak V˙ O2: family members, 1.80.6
L/min; control subjects, 2.20.5 L/min). Normal distribution
of TRV values was not found during exercise and after 120
minutes of hypoxia, at which point a takeoff pattern begin-
ning at 3.08 m/s was observed. This is due to a subgroup of
control subjects with a hypertensive TRV response to exer-
cise and hypoxia (Figure 2B). The subgroup of control
subjects with higher TRV during exercise and/or hypoxia
caused a separate peak in the distribution of values (analyzed
by the descriptive kernel density estimation of TRV) at 3.5
m/s, whereas the majority of control subjects had a peak TRV
during exercise or hypoxia at 2.8 m/s (Figure 3C and 3D).
This separate second peak of TRV was seen during exercise
and hypoxia even when corrected for center effects (Figure
3A). Among the group of relatives, a significantly larger
subgroup of subjects was found with TRV values 3.08 m/s
during exercise and hypoxia than in the control group, causing
a second peak in the distribution at 3.5 m/s (Figure 3F and
3G). This separate peak was seen in all centers (not shown).
Threshold of Maximal TRV in Controls
The cutoff TRV value discriminating between control sub-
jects showing a normal distribution of values (normal re-
sponse [NR]) and those with hypertensive response to exer-
cise and/or hypoxia (HR) was predefined by the 90% quantile
of maximal TRV in control subjects. Applying this criterion,
we obtained a cutoff TRV of 3.08 m/s. Thus, control subjects
and relatives with a TRV 3.08 m/s (corresponding to PASP
values 43 mm Hg) during low-dose exercise (up to 125 W)
and/or during 120 minutes of hypoxia were characterized as
subjects with hypertensive pulmonary artery pressure re-
sponse (HR).
Comparison of TRV During Exercise and Hypoxia
Between Relatives and Control Subjects
At rest, mean TRV and mean PASP did not differ between
relatives (20.75.4 mm Hg) and control subjects
(20.45.3 mm Hg; P0.45; Tables 3 and 4). During exer-
cise, mean maximal TRV was significantly higher in relatives
than in control subjects (P0.0001), although control sub-
jects reached a higher mean maximal workload (14844 W)
than relatives (12442 W). In addition, during hypoxia,
mean maximal TRV was significantly higher in relatives than
in control subjects (P0.0001). The generalized estimating
approach was used to control for center effects. These
differences were not related to age or sex. These statistical
tests between groups were corrected for centers and familial
relation; the mean values for each family were used for
calculation. During exercise, 31.6% of relatives but only 10%
of control subjects had TRV values 3.08 m/s (Figure 4).
During hypoxia, 26% of relatives had values 3.08 m/s
compared with 10% of control subjects (Figure 4).
PASP Changes During Exercise and
During Hypoxia
During exercise and hypoxia, mean PASP increased signifi-
cantly more in relatives compared with control subjects
Table 1. Study Population of Each Center
Centers, n
Bologna Brussels Warsaw Clamart Giessen Heidelberg Total
Index patients 10 10 19 19 26 25 109
Relatives 12 35 56 55 67 66 291
Control subjects 10 36 25 30 23 67 191
Table 2. Characteristics of Relatives and Control Subjects
Characteristics
Subjects Assessed by Stress
Echocardiography per Protocol Set
Subjects Assessed During Hypoxia per
Protocol Set
Relatives (n291) Controls (n191) Relatives (n131) Controls (n113)
Female sex, % 43 48 46 40
Age, y 3716 3210 3616 3111
Height, cm 1699 1739 17010 17310
Weight, kg 6915 6812 7015 6712
SBP, mm Hg 12520 12214 12622 12215
DBP, mm Hg 7814 7711 7715 7511
Heart frequency, bpm 7613 7413 7412 7212
Smoker, % 22 16 22 20
SBP indicates systolic blood pressure; DBP, diastolic blood pressure. Data are meanSD unless otherwise
indicated.
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(Table 4). Mean PASP during exercise increased from
20.75.4 to 39.55.6 mm Hg (PASP, 18.810.6 mm Hg)
in relatives and from 20.45.3 to 35.55.4 mm Hg (PASP,
15.27.1 mm Hg; P0.0001) in control subjects. The same
effect was observed during 120 minutes of hypoxia; PASP
rose from 20.75.4 to 38.45.7 mm Hg (PASP,
19.79.5 mm Hg) in relatives and from 20.45.3 to
33.75.5 mm Hg (PASP, 14.48.1 mm Hg; P0.0029) in
control subjects. The maximal TRV values were found
between 90 and 120 minutes of hypoxia. Mean oxygen satura-
tion after 60, 90, and 120 minutes of hypoxia was similar in the
subjects assessed in Brussels, Giessen, and Heidelberg, although
different methods for hypoxic testing were used (facial mask and
hypoxic chamber; Table 3). Maximal PASP of relatives during
exercise ranged between 17 and 77 mm Hg; in control subjects,
it ranged between 20 and 68 mm Hg.
Comparison of PASP in HR and NR Subjects of
Relatives and Control Subjects
HR and NR subjects among the relatives had similar TRV
and PASP values at rest. During exercise, mean PASP
increased to significantly higher levels in HR relatives
(PASP, 28.89.1 mm Hg) than in NR relatives (PASP,
12.76.2 mm Hg). During exercise and hypoxia, a 2- to
3-fold greater increase in mean PASP was found in the HR
compared with the NR subjects. This increase was already
evident at low workloads between 50 and 125 W and/or
within the first 45 minutes of hypoxia and reached a maxi-
mum between 90 to 120 minutes of hypoxia (PASP,
30.410.3 mm Hg in HR versus 15.85.3 mm Hg in NR).
These increases in TRV and PASP during exercise and
hypoxia were similar in the HR subjects among both the
relatives and control subjects.
Identification of Subjects With Hypertensive TRV
During Exercise and Hypoxia
When we analyzed all subjects who completed both exercise
and hypoxia assessments (111 control subjects, 130 rela-
tives), we found that during exercise TRV values exceeded
3.08 m/s in 10 control subjects and in 43 relatives. TRV
values exceeded 3.08 m/s in 7 of the 10 HR control subjects
during exercise and during hypoxia, in 3 of these control
subjects during exercise only, and in 4 control subjects during
hypoxia only (Figure 5). In contrast, 101 control subjects had
TRV values 3.08 m/s during exercise: 97 during exercise
and hypoxia and 4 during exercise only. Thus, the positive
predictive value for identifying HR subjects among control
subjects using supine bicycle exercise and an upper limit of
normal TRV of 3.08 m/s was 64% (95% confidence interval
[CI], 30.1 to 89.1), and the negative predictive value was 97%
(95% CI, 91.5 to 99.4). Within the group of relatives, the
positive predictive value was 60.5% (95% CI, 22.3 to 89.1),
and the negative predictive value was 91.1% (95% CI, 95.8 to
95), both adjusted for familial relations.
Correlation of TRV With Baseline Variables
in Controls
Mean TRV values at rest and during exercise and hypoxia in
control subjects did not differ significantly between men and
women and between smokers and nonsmokers and were not
significantly related to age, sex, systolic or diastolic blood
pressure, heart rate, and body mass index (Figure 6). In
control subjects, a significant but weak correlation was found
of TRV at rest with values during exercise (r0.27,
P0.0002; Figure 6Af) and during hypoxia (r0.43,
P0.0087; not shown).
Correlation of TRV With Baseline Variables
in Relatives
TRV values at rest did not correlate with body mass index or
systolic or diastolic blood pressure but did correlate with age
(r0.13, P0.03). TRV during exercise in relatives was
weak but significantly correlated with body mass index
(r0.16, P0.0029), age (r0.28, P0.0001), systolic
blood pressure (r0.223, P0.0001), diastolic blood pres-
sure (r0.12, P0.0379), and TRV at rest (r0.17,
P0.0043). Relatives with higher values on these parameters
generally also showed higher TRV. TRV during hypoxia was
weak but significantly correlated with body mass index
(r0.19, P0.0343), age (r0.38, P0.0001), systolic
blood pressure (r0.21, P0.0128), TRV at rest (r0.39,
P0.0001), and TRV during exercise (r0.47, P0.0001).
Genetic Analysis
All P values have been adjusted for familial clustering.
Genetic analysis was performed in 109 of 122 recruited index
patients with I/FPAH. Of these 109 index patients, 31 had a
family history of PAH and were classified as FPAH; 78 were
classified as IPAH. In 35 of the 109 index patients and in 16
family members of these 35 patients, a BMPR2 mutation was
found (group A; Figure 7). Sixteen of the 31 patients with
FPAH (52%) and 19 of the 78 IPAH patients (24%) carried a
BMPR2 mutation. No BMPR2 mutation was found in 63
Figure 2. A Q-Q plot with the distribution of TRV values among
healthy control subjects (A) at rest and (B) during exercise. A, All
TRV values obtained at rest range on a straight line as expected
in a normal distribution of values. B, During exercise, TRV val-
ues display a deviation of normal distribution as a result of a
proportion of subjects with higher TRV values.
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relatives of the BMPR2-positive index patients (group B) and
74 index patients and their relatives (group C; n197). In 15
relatives, no genetic testing was performed. Mean maximal
TRV during exercise was significantly higher in relatives
with BMPR2 mutation (n16; 3.050.41 m/s) than in
relatives without BMPR2 mutation (n260; 2.870.43 m/s;
P0.029). The group of relatives with BMPR2 mutation
(group A) had a significantly higher proportion of HR
subjects (50.0%) than relatives without mutation (29.6%;
95% CI, 24.1 to 35.6; group BC; P0.019; Figure 7). The
proportion of HR between the BMPR2 mutation–positive
(group A, 50.0%; 95% CI, 24.7 to 75.4) and BMPR2
mutation–negative relatives (group B, 28.6%; 95% CI, 17.9
to 41.4) of BMPR2 mutation–positive index patients also was
significantly different (P0.045). Mean TRV at rest (group
A [n16], 2.00.25 m/s; group BC [n260], 1.920.31
m/s; P0.7) and mean maximal TRV during hypoxia (group
A [n12], 2.970.65 ms; group BC [n121], 2.900.39
m/s; P0.71) were not significantly different between the
relatives of group A compared with those in group BC.
Of the 291 relatives receiving echocardiography assess-
ment, 71% were related to the index patient in the first degree
and 29% in the second degree. Nine percent of both the first-
and second-degree relatives carried a BMPR2 mutation. Rela-
tives of BMPR2-positive index patients did not show a signifi-
cantly different proportion of first- and second-degree relatives
between the different groups (group A versus B; Figure 7). The
group of BMPR2-negative relatives (n63) consisted of 58%
first-degree and 42% second-degree relatives. In comparison, the
group of BMPR2-positive relatives (n16) consisted of 69%
first-degree and 31% second-degree relatives.
Discussion
This is the first prospective multicenter study devoted to screen-
ing for exercise- and hypoxia-induced PH in relatives of I/FPAH
patients and to investigate the threshold of normal pulmonary
artery pressures during exercise in a large collective of healthy
control subjects. One main finding of this study is that relatives
of patients with I/FPAH have a significantly higher frequency of
HR to exercise and to prolonged hypoxia than control subjects.
The highest proportion of HR subjects was found in relatives
who shared a BMPR2 mutation with the index patients. The data
of this study suggest that a hypertensive pulmonary artery
pressure response to exercise and hypoxia is genetically deter-
mined with a familial clustering.
Figure 3. Density of TRV values in healthy control subjects (B through D) and relatives of IPAH patients (E through G). In the control subjects
at rest (B), TRV values are normally distributed without a second peak of maximal values. During exercise (C) and during prolonged hypoxia
(D), the density of TRV values is at least bimodal, with a second peak at 3.5 m/s representing the subgroup of subjects (10%) with hyper-
tensive TRV response to exercise and hypoxia. Among the group of relatives (F and G), the second peak of values is not separated and has
a larger area under the curve because of the higher proportion of subjects with hypertensive TRV response to exercise (F) or hypoxia (G). The
calculated density profile in center subgroups is shown (A). Arrows delineate the second peaks of higher TRV values.
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Hypertensive TRV Response and BMPR2 Gene
To the best of our knowledge, this is the largest study so far
of healthy control subjects and relatives of I/FPAH patients
using echocardiography in 482 subjects during exercise and
244 subjects during prolonged hypoxia. Patients, their rela-
tives, and control subjects were recruited in 6 European
centers (5 countries) specializing in PH. Thus, the study
population represents at least 3 different white populations. All
centers found a variation of pulmonary artery pressures in
control subjects and in relatives of PAH patients, with a
proportion of subjects showing a hypertensive TRV during
exercise and prolonged hypoxia (HR) not yet described in a
larger population. Previous studies in small study populations
have shown that pulmonary artery pressures during exercise are
greatly variable among normal young individuals, some of
whom show little change and some show large increments,
Table 3. TRV in Different Groups
Characteristics TRV at Rest, m/s
Maximum TRV During
Exercise, m/s
TRV During
Hypoxia, m/s
SaO2 During Hypoxia
At 60 min, % At 90 min, % At 120 min, %
Sex (all subjects)
Men 1970.29 2.860.38 2.800.42         
Women 1.970.28 2.810.40 2.820.38         
Smoking (all subjects)
Smokers 1.990.29 2.800.40 2.790.40         
Nonsmokers 1.970.28 2.850.39 2.810.40         
Group
Controls 1.960.25 2.760.30* 2.680.35*         
Relatives 1.980.31 2.890.43* 2.920.41*         
Center (controls)
Giessen 1.940.27 2.970.44 2.870.39         
Heidelberg 1.850.30 2.900.35 2.660.39         
Brussels 1.930.24 2.700.37 2.910.37         
Bologna 1.990.29 2.850.32            
Clamart 2.150.26 2.860.36            
Warsaw 1.990.23 2.690.39            
All subjects
Giessen          76.07.7 74.38.6 76.38.5
Heidelberg          76.66.5 75.86.5 77.06.3
Brussels          74.95.8 73.56.3 72.46.2
Values are given as meanSD. TRV values were compared between subgroups: men versus women (PNS), smokers versus nonsmokers (PNS),
control subjects versus relatives (*P0.05), and between centres (global P0.05).
Table 4. Mean TRV and PASP at Rest and During Different Stages of Exercise and Hypoxia in
Family Members and Control Subjects
TVR
TVR per Protocol Set, m/s PASP per Protocol Set, mm Hg
Relatives (n291) Controls (n191) Relatives (n291) Controls (n191)
During exercise
At rest 1.980.31 1.960.25 20.75.4 20.45.3
25 W 2.430.43 2.320.31 28.65.7 25.55.4
50 W 2.640.48 2.490.34 32.95.9 29.85.5
75 W 2.800.49 2.610.32 36.45.9 32.55.4
100 W 2.860.40 2.670.33 37.75.6 33.55.4
125 W 2.940.37 2.810.31 39.55.6 35.55.4
During hypoxia
30 min 2.450.36 2.310.35 29.05.5 26.35.5
60 min 2.60.43 2.460.35 32.05.7 29.15.5
90 min 2.780.42 2.590.37 36.15.7 31.95.6
120 min 2.900.46 2.700.38 38.85.8 34.25.8
Values are given as meanSD.
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depending on the exercise intensity.25 In the present study, we
found that these variations can be assigned to a bimodal
distribution of maximal TRV values with a separate peak caused
by the HR subgroup (Figure 3). HR subjects among relatives and
control subjects had a distinct phenotype, with a 2- to 3-fold
greater increase in mean TRV already during low levels of
exercise (50 to 125 W) and/or during prolonged hypoxia
compared with NR subjects. Some HR subjects reached peak
PASP values of up to 80 mm Hg. The finding of HR in relatives
confirms the findings of a previous study in 2 families with
FPAH.8 The mechanisms underlying the exaggerated pulmonary
artery pressure response are currently unknown, with loss of
pulmonary vasodilatory capacity, reduced distensibility, and
inadequate/excessive vasoconstriction, as observed in subjects
exposed to chronic hypoxia,26 being discussed. The finding of a
significantly higher proportion of HR subjects in I/FPAH rela-
tives with BMPR2 mutation compared with relatives without
BMPR2 mutation and compared with control subjects suggests
that the HR phenotype—at least in I/FPAH—is genetically
determined. However, the clinical implications of this finding
are currently unknown. It is unlikely that the BMPR2 mutations
themselves cause HR for the following reasons. Not all subjects
with a BMPR2 mutation showed HR. Furthermore, relatives
without BMPR2 mutation also revealed a significantly higher
proportion of HR subjects compared with control subjects (92 of
291 versus 19 of 191; P0,0001). Thus, HR may be distributed
within the I/FPAH families as another genetic trait.
Our findings indicate that variation in TRV response to
exercise and hypoxia is likely to be a “common” trait within
the general population. It can be speculated that the “HR
gene/s” may be necessary cofactor/s in an epistatic I/FPAH
disease model supporting the previously suggested “second-
hit” hypothesis.27 To address these questions, long-term
follow-up studies are necessary. The molecular basis of the
hypertensive TRV response requires further investigation.
Hypertensive TRV Response to Hypoxia
Interestingly, TRV response to exercise correlated highly with
the response to hypoxia. TRV values in HR subjects were in the
same range as observed in individuals susceptible to high-
altitude pulmonary edema.19 Thus, the question arises whether
HR subjects in general are prone to develop high-altitude
pulmonary edema and whether subjects susceptible to high-
altitude pulmonary edema carry the same genetic disposition
(HR gene/s).
Threshold of Normal TRV in Healthy
Control Subjects
Traditionally it has been assumed that TRV 2.5 m/s,
corresponding to PASP 35 mm Hg, during exercise repre-
sents the upper limit in healthy persons.20,28,29 However, no
clear guidelines that distinguish normal from pathological
Figure 4. Histograms of TRV values at rest and during exercise
and hypoxia in control subjects vs relatives. Bold horizontal line
indicates the TRV cutoff value at 3.08 m/s separating subjects with
hypertensive TRV response during exercise (B) and hypoxia (C).
Figure 5. Scatterplot of maximum TRV values during hypoxia vs
exercise in relatives (yellow) and control subjects (blue).
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pulmonary artery pressure levels are available, particularly
for Doppler echocardiography during exercise. The cutoff
TRV value of 3.08 m/s (corresponding to 43 mm Hg PASP)
defined in this study and separating NR from HR subjects
was determined by measurements in a large number of
healthy control subjects; 3.08 m/s was identical to the value
obtained by density analysis and close to the mean peak value
plus 1 SD (3.06-m/s TRV42.4-mm Hg PASP). Further-
more, this threshold is very consistent with previous inva-
sive30 and noninvasive15,31,32 studies that demonstrated mild
increases in pulmonary arterial pressure with exercise in a
normal population. However, this cutoff level might not be
adequate in subjects with 60 years of age or at higher
workloads (150 W) and for athletes, TRV and PASP can
Figure 6. Scatterplots demonstrating the correlation of TRV values (A) at rest and (B) during exercise in control subjects with the baseline variables
age, BMI, systolic blood pressure (SBP), diastolic blood pressure (DBP), heart rate frequency (HF), sex, and TRV values during exercise.
Figure 7. Genetic results. Flowchart of enrolled
patients and relatives. Relatives carrying a BMPR2
mutation had a hypertensive TRV significantly
more often during exercise and/or hypoxia (HR)
than individuals without a BMPR2 mutation.
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exceed 3.08 m/s and 43 mm Hg, respectively.15 We used a
fixed right atrial pressure estimate of 5 mm Hg if the inferior
vena cava was 20 mm. This may slightly underestimate or
overestimate the true values, but given the consistency of this
value between groups, it did not likely influence the results.
Correlation of TRV Values With
Baseline Variables
Another major finding of this study is that TRV in control
subjects at rest was not related to age, sex, systolic or diastolic
blood pressure, and body mass index as suggested by McQuillan
et al.33 McQuillan et al evaluated PASP retrospectively from a
database that did not explicitly exclude patients with coronary
artery disease and/or pulmonary diseases. In our cohort, the TRV
values were obtained prospectively, and subjects with systemic
hypertension or other cardiopulmonary diseases were excluded.
Nevertheless, we cannot exclude that other populations at an
older age may present different results.
Clinical Implications
This study provides a basis for assessment of exercise- and
hypoxia-induced PH. The clinical significance of a hyperten-
sive pulmonary artery pressure response to exercise and
hypoxia, however, is currently unsettled. It may reflect a
normal variation of pulmonary artery pressures without clin-
ical significance, or it may be related to some limitation in
exercise capability that is relevant only under stress condi-
tions. However, it may also reflect a genetic trait associated
with increased risk for the development of PH or high-
altitude pulmonary edema. In particular, the putative risk of
developing PH among “HR-positive” relatives of I/FPAH
patients must be discussed very cautiously. HR is also seen in
healthy control subjects, although at a lower percentage than
in I/FPAH relatives. Moreover, even if HR should turn out to
reflect an enhanced risk for manifest PH development, the
number of individuals identified as HR will be much higher
than the number of subjects who will eventually develop the
disease because of incomplete penetrance or possible further
contributing factors. Follow-up assessments in relatives of
I/FPAH patients are mandatory to clarify whether the HR
state indeed reflects an enhanced risk to develop manifest PH
and at what percentage. This will provide a basis to decide
whether stress echocardiography is an appropriate tool for
early diagnosis of PH.
Although great effort was necessary to standardize the
echocardiographic examination and to obtain high-quality TRV
profiles, the study showed that this screening approach is
applicable in clinical settings. The TRV/PASP assessments
during exercise and hypoxia are practicable and safe noninvasive
tests to identify HR with high sensitivity and specificity. How-
ever, the true reliability of stress Doppler echocardiography
during exercise or hypoxemia is currently unknown. The sensi-
tivity of hypoxic and exercise testing is comparable and may
even be improved further when both are combined. TRV/PASP
is easier to assess during hypoxia than during exercise because
the subjects do not move during the examination, and in most
subjects, the tricuspid regurgitation profile is even more accen-
tuated during hypoxia than at rest in normoxia or during
exercise. Nevertheless, it is not clear whether 1 of the 2 methods
should be preferred for provocation of the HR.
Conclusions
Pulmonary hypertensive response to exercise and hypoxia in
I/FPAH relatives appears in part to be a genetic trait with
familial clustering, being correlated with but not caused by a
BMPR2 mutation. The clinical meaning of a hypertensive
pulmonary artery pressure response to exercise and hypoxia
remains unclear and should be addressed in long-term
follow-up studies.
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CLINICAL PERSPECTIVE
This is the first prospective multicenter study with Doppler stress echocardiography devoted to screening for exercise- and
hypoxia-induced pulmonary hypertension in relatives of idiopathic or familial pulmonary arterial hypertension patients and to
investigate the threshold of normal pulmonary artery pressures during exercise in a large collective of healthy control subjects.
One main finding of this study is that relatives of patients with idiopathic or familial pulmonary arterial hypertension have a
significantly higher frequency of a hypertensive tricuspid regurgitation velocity response to exercise and to prolonged hypoxia
than control subjects. The highest proportion of subjects with hypertensive tricuspid regurgitation velocity response was found
in relatives who shared a BMPR2 mutation with the index patients. The data in this study suggest that a hypertensive pulmonary
artery pressure response to exercise and hypoxia is genetically determined with familial clustering. The clinical significance of
hypertensive pulmonary artery pressure response to exercise and hypoxia, however, is currently unsettled. It may reflect a normal
variation in pulmonary artery pressures without clinical significance, or it may be related to some limitation in exercise capability
that is relevant only under stress conditions. However, it may also reflect a genetic trait associated with increased risk for the
development of pulmonary hypertension or high-altitude pulmonary edema. Although great effort was necessary to standardize
the echocardiographic examination and to obtain high-quality tricuspid regurgitation velocity profiles, the study showed that this
screening approach is applicable in clinical settings. Follow-up assessments in relatives of idiopathic or familial pulmonary
arterial hypertension patients may provide a basis to decide whether stress echocardiography is an appropriate tool for early
diagnosis of pulmonary arterial hypertension.
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